Clinical Trial Update: Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of Stribild versus Atripla in antiretroviral-naive adults with HIV-1 infection; results were posted after study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-10-22